PET Scans With 18F-Fluorodeoxyglucose to Diagnose Adrenal Tumors-Reply.
作者信息
Taïeb David, Pacak Karel
机构信息
Department of Nuclear Medicine, Aix-Marseille University, Marseille, France.
Section on Medical Neuroendocrinology, National Institute of Child Health and Human Development, Bethesda, Maryland.
出版信息
JAMA. 2017 Oct 24;318(16):1614-1615. doi: 10.1001/jama.2017.13759.
Abstract
摘要
相似文献
1
PET Scans With 18F-Fluorodeoxyglucose to Diagnose Adrenal Tumors-Reply.
JAMA. 2017 Oct 24;318(16):1614-1615. doi: 10.1001/jama.2017.13759.
2
PET Scans With 18F-Fluorodeoxyglucose to Diagnose Adrenal Tumors.
JAMA. 2017 Oct 24;318(16):1614. doi: 10.1001/jama.2017.13748.
3
18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
World J Surg. 2010 Jul;34(7):1506-10. doi: 10.1007/s00268-010-0576-3.
4
High 18F-Fluorodeoxyglucose Uptake in Adrenal Angiomyolipoma: Case Report and Review of Literature.
Medicine (Baltimore). 2015 Jun;94(22):e900. doi: 10.1097/MD.0000000000000900.
5
Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.
Nucl Med Commun. 2011 Sep;32(9):764-81. doi: 10.1097/MNM.0b013e3283478a2a.
6
High affinity of 18F-FDG in rare tumors. Initial study and monitoring by PET/CT in a case of adrenal adenocarcinoma.
Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):266-8. doi: 10.1016/j.remn.2012.10.002. Epub 2012 Dec 4.
7
Adrenal myelolipoma: an unusual cause of bilateral highly 18F-FDG-avid adrenal masses.
J Clin Endocrinol Metab. 2012 Aug;97(8):2577-8. doi: 10.1210/jc.2012-1713. Epub 2012 May 23.
8
Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging.
J Int Med Res. 2010 Mar-Apr;38(2):633-44. doi: 10.1177/147323001003800226.
9
Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Diagn Interv Radiol. 2013 Jul-Aug;19(4):294-8. doi: 10.5152/dir.2013.048.
10
Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT.
Jpn J Radiol. 2009 Nov;27(9):392-3. doi: 10.1007/s11604-009-0358-8. Epub 2009 Nov 27.
引用本文的文献
1
Cellular and molecular imaging for stem cell tracking in neurological diseases.
Stroke Vasc Neurol. 2021 Mar;6(1):121-127. doi: 10.1136/svn-2020-000408. Epub 2020 Oct 29.
本文引用的文献
1
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2465-2472. doi: 10.1210/jc.2017-00254.
2
MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis.
Eur J Endocrinol. 2016 Aug;175(2):R51-64. doi: 10.1530/EJE-16-0461. Epub 2016 Jun 2.
3
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Eur J Endocrinol. 2015 Dec;173(6):749-56. doi: 10.1530/EJE-15-0707. Epub 2015 Sep 7.
4
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S714-20. doi: 10.1245/s10434-015-4813-8. Epub 2015 Aug 18.
5
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
J Clin Oncol. 2008 May 1;26(13):2155-61. doi: 10.1200/JCO.2007.14.5631. Epub 2008 Mar 24.
Zotero 插件